Literature DB >> 1337913

Ouabain, digitalis-like factors and hypertension.

J M Hamlyn1, P Manunta.   

Abstract

PURPOSE: To review the evidence that ouabain and other digitalis-like factors are present in the human circulation under normal circumstances and in various disorders of fluid and electrolyte balance that are associated with hypertension. CONTENT: Recent evidence on a number of ouabain-related issues includes (1) evidence for the existence of inhibitors of sodium pumps in mammalian plasma, (2) the identification of one of these factors as ouabain, (3) measurements of plasma levels of ouabain in man, (4) evidence that ouabain causes chronic hypertension in rats and is associated with human hypertension, and (5) data on some probable mechanisms that may mediate the pressor effect.
CONCLUSIONS: The available data support the novel hypothesis that ouabain is an endogenous circulating agent in man and other mammals and is likely to influence long-term blood pressure levels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1337913

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  11 in total

1.  Reduction of Na/K-ATPase potentiates marinobufagenin-induced cardiac dysfunction and myocyte apoptosis.

Authors:  Changxuan Liu; Yan Bai; Yiliang Chen; Yu Wang; Yoann Sottejeau; Lijun Liu; Xiaomei Li; Jerry B Lingrel; Deepak Malhotra; Christopher J Cooper; Joseph I Shapiro; Zi-jian Xie; Jiang Tian
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

2.  Contacts and cooperation between cells depend on the hormone ouabain.

Authors:  Isabel Larre; Arturo Ponce; Rosana Fiorentino; Liora Shoshani; Rubén G Contreras; Marcelino Cereijido
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-11       Impact factor: 11.205

Review 3.  Endogenous cardiotonic steroids and salt-sensitive hypertension.

Authors:  Olga V Fedorova; Joseph I Shapiro; Alexei Y Bagrov
Journal:  Biochim Biophys Acta       Date:  2010-03-27

Review 4.  Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.

Authors:  Xiaoliang Wang; Jiang Liu; Christopher A Drummond; Joseph I Shapiro
Journal:  Expert Opin Ther Targets       Date:  2017-04-03       Impact factor: 6.902

5.  Effect of ouabain on myocardial ultrastructure and cytoskeleton during the development of ventricular hypertrophy.

Authors:  Shao-hua Zhao; Hai-qing Gao; Xiang Ji; Yan Wang; Xiang-ju Liu; Bei-an You; Xiao-pei Cui; Jie Qiu
Journal:  Heart Vessels       Date:  2012-01-13       Impact factor: 2.037

Review 6.  How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension.

Authors:  Mordecai P Blaustein; Frans H H Leenen; Ling Chen; Vera A Golovina; John M Hamlyn; Thomas L Pallone; James W Van Huysse; Jin Zhang; W Gil Wier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

7.  On the structure of endogenous ouabain.

Authors:  A Kawamura; J Guo; Y Itagaki; C Bell; Y Wang; G T Haupert; S Magil; R T Gallagher; N Berova; K Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

8.  Insulin resistance is associated with high plasma ouabain-like immunoreactivity concentration in NIDDM.

Authors:  T Wasada; H Kuroki; M Naruse; H Arii; A Maruyama; K Katsumori; S Saito; Y Watanabe; K Naruse; H Demura
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

9.  Contribution of the endothelin and renin-angiotensin systems to the vascular changes in rats chronically treated with ouabain.

Authors:  Fabiano E Xavier; Alvaro Yogi; Gláucia E Callera; Rita C Tostes; Yolanda Alvarez; Mercedes Salaices; María J Alonso; Luciana V Rossoni
Journal:  Br J Pharmacol       Date:  2004-10-11       Impact factor: 8.739

10.  Reduction of Na/K-ATPase affects cardiac remodeling and increases c-kit cell abundance in partial nephrectomized mice.

Authors:  Christopher A Drummond; Moustafa Sayed; Kaleigh L Evans; Huilin Shi; Xiaoliang Wang; Steven T Haller; Jiang Liu; Christopher J Cooper; Zijian Xie; Joseph I Shapiro; Jiang Tian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-04-18       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.